Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Breast Cancer With Adjacent Normal Breast Equipment Supplied In Europe
61 equipment items found
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Breast cancer with adjacent normal breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245. Breast carcinoma with adjacent normal breast tissue ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of postmenopausal women with estrogen-responsive breast ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
The marker of proliferation MKI67 is a nuclear protein associated with cell proliferation. MKI67 protein is present during all active phases of the cell cycle (G1, S, G2, and mitosis), but is absent from resting cells (G0). In Breast Cancer MKI67 expression is a prognostic marker for survival and tumour ...
by:Cymit Química S.L. based inBarcelona, SPAIN
4-Methylumbelliferyl lignocerate is a synthetic fatty acid that inhibits the growth of cancer cells. It has been shown to have an inhibitory effect on breast cancer cell lines, such as MDA-MB-231 and MCF-7. ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The Mimetix fibres are labelled with Rhodamine 6G. The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
The Estrogen receptor 1 gene (ESR1) belongs to the family of steroid receptors. The protein is expressed intracellularly. It is a transcription factor regulating the expression of genes and is activated by estrogen. Estrogen receptors are overexpressed in about 70 % of all Breast Cancer cases. There are hypotheses, that overexpression causes tumourigenesis. ESR1 overexpressing tumours can be ...
Manufactured by:Illumina Inc. based inSan Diego, CALIFORNIA (USA)
Targeted research panel investigating somatic and germline variants in BRCA1 and ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
ERBB2 is the name of the gene for human epidermal growth factor receptor 2 (HER2). This receptor is a cell surface protein which belongs to the family of epidermal growth factor receptors. ERBB2 activation stimulates cell proliferation and inhibits programmed cell death. ERBB2 has an important role in Breast Cancer. About 20 % of all Breast Cancers show an overexpression of this receptor, which ...
Manufactured by:OncoQR ML GmbH based inBreitenfurt, AUSTRIA
Lead candidate OQR200 is a new candidate against HER2/neu, the by far best characterized and clinically validated target to treat breast cancer indications. A reversible induction of HER2/neu specific antibodies has been demonstrated. In vitro, the immune response induced by OQR200 has been shown to have superior efficacy in a direct side by side comparison with successful clinical products ...
by:RaySearch Laboratories based inStockholm, SWEDEN
Save time and reduce the risk of error by automating treatment planning. Advanced plan-generating protocols, scripting, automated breast planning, fallback planning, machine learning and plan explorer are some of the tools available in RayStation — the first treatment planning system to incorporate machine learning applications. ...
Manufactured by:Cerca Biotech based inBerlin, GERMANY
The progesterone receptor (PGR) also belongs to the gene family of steroid receptors. Upon binding of progesterone, the receptor is activated and modifies expression of several downstream genes. Estrogen and progesterone receptors are found in Breast Cancer cells that depend on estrogen and related hormones (such as progesterone) to grow. All patients with invasive Breast Cancer or a Breast ...
Manufactured by:ScreenPoint Medical based inNijmegen, NETHERLANDS
The resulting product, Transpara, has featured in multiple peer-reviewed publications that show it enables significant clinical improvements to the timely diagnosis of breast cancer. “Transpara is now being used by radiologists in clinical practice, but this is only the beginning! We are constantly innovating and we will continue to help doctors to achieve higher breast cancer survival ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Pheophorbide a is a chlorophyll-related compound studied for its anti-tumor and anti-cancer ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
Based on our proven CE-marked MSOT Acuity Echo system further non-CE-certified, customized MSOT Acuity Echo research systems are available upon request to match your clinical research needs in optoacoustic imaging. iThera Medical has been providing optoacoustic systems for clinical research since 2014. Two product lines, the MSOT Acuity Echo and the RSOM Explorer C50 research system, enable ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
It takes 300 screening mammograms to discover one woman with breast cancer. A breath test might improve this very low yield. Researchers have known for many years that women with breast cancer have abnormal volatile organic compounds (VOCs) in their breath. Clinical studies at Menssana Research have shown that these breath VOCs can accurately identify women with early stage breast cancer or an ...
Manufactured by:Care Wise Medical Products Corporation based inHENFIELD, UNITED KINGDOM
C-Trak Apollo wireless and wired gamma probe for radio guided surgery.Superior directionality and complete flexibility. The C-Trak Apollo gamma probe allows for the detection of radiation during sentinel node biopsies, parathyroid and tumour localisation. The C-Trak Apollo’s distinctive feature is our superior sensitivity and directionality, but now we also offer wired and wireless ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
Ascites is also a common complication of certain late-stage cancers due to fluid build-up in the peritoneal cavity from a number of causes including draining of the lymph system. While life expectancy for many cancer patients with malignant ascites is short (less than 3 months), ovarian and breast cancer patients often have longer life expectancies. In 2018, the incidence in the U.S. and EU5 is ...
by:Exact Sciences UK, Ltd. based inLondon, UNITED KINGDOM
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
Elucigene DPYD assay is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered. 5-fluorouracil (5-FU) is a chemotherapy agent used to treat a range of cancers including colorectal, head and neck, breast, pancreatic and stomach cancer. 5-FU is metabolized by the dihydropyrimidine dehydrogenase enzyme (DPD) which is encoded by the ...